Literature DB >> 11001666

Leukocyte concentration in the performance of the pp65 antigenemia assay.

S M Lipson, P Della-Latta.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 11001666      PMCID: PMC87216          DOI: 10.1128/JCM.38.8.3137-3138.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  14 in total

1.  Comparison of PCR, antigenemia assay, and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantation.

Authors:  A Weinberg; T N Hodges; S Li; G Cai; M R Zamora
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  A multisite trial comparing two cytomegalovirus (CMV) pp65 antigenemia test kits, biotest CMV brite and Bartels/Argene CMV antigenemia.

Authors:  K St George; M J Boyd; S M Lipson; D Ferguson; G F Cartmell; L H Falk; C R Rinaldo; M L Landry
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

3.  2-Hour cytomegalovirus pp65 antigenemia assay for rapid quantitation of cytomegalovirus in blood samples.

Authors:  M L Landry; D Ferguson
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients.

Authors:  B S Blank; P L Meenhorst; J W Mulder; G J Weverling; H Putter; W Pauw; W C van Dijk; P Smits; S Lie-A-Ling; P Reiss; J M Lange
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

5.  Comparison of three assays for cytomegalovirus detection in AIDS patients at risk for retinitis.

Authors:  P Wattanamano; J L Clayton; J J Kopicko; P Kissinger; S Elliot; C Jarrott; S Rangan; M A Beilke
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

6.  An increase in the number of polymorphonuclear leukocytes inoculated on shell-vial culture increases the sensitivity of this assay in the detection of cytomegalovirus in the blood of immunocompromised patients.

Authors:  J Reina; J Saurina; V Fernandez-Baca; I Blanco; M Munar
Journal:  Diagn Microbiol Infect Dis       Date:  1998-07       Impact factor: 2.803

7.  Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test.

Authors:  K K Dodt; P H Jacobsen; B Hofmann; C Meyer; H J Kolmos; P Skinhøj; B Norrild; L Mathiesen
Journal:  AIDS       Date:  1997-03       Impact factor: 4.177

8.  Cytomegalovirus antigenemia in acquired immunodeficiency syndrome patients with untreated cytomegalovirus retinitis.

Authors:  C S Pannuti; E G Kallás; C Muccioli; R K Roland; E C Ferreira; S M Bueno; C L Do Canto; L S Villas Boas; R Belfort Júnior
Journal:  Am J Ophthalmol       Date:  1996-12       Impact factor: 5.258

9.  Effect of leukocyte concentration and inoculum volume on the laboratory identification of cytomegalovirus in peripheral blood by the centrifugation culture-antigen detection methodology.

Authors:  S M Lipson; L H Falk; S H Lee
Journal:  Arch Pathol Lab Med       Date:  1996-01       Impact factor: 5.534

10.  Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia.

Authors:  G Gerna; M G Revello; E Percivalle; F Morini
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.